ARCT-021 two higher dose priming

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy AdultsNCT04668339Arcturus Therapeutics, Inc.Phase 2Terminated2022-03-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.